Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer.
about
Study protocol to investigate the effect of a lifestyle intervention on body weight, psychological health status and risk factors associated with disease recurrence in women recovering from breast cancer treatment [ISRCTN08045231].Hypoalbuminemia in colorectal cancer prognosis: Nutritional marker or inflammatory surrogate?Personalized medicine in sporadic pancreatic cancer without homologous recombination-deficiency: are we any closer?Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinomaTumor macroenvironment and metabolism.Predicting survival time in noncurative patients with advanced cancer: a prospective study in China.Metabolic syndrome and elevated C-reactive protein in breast cancer survivors on adjuvant hormone therapyUsing SCC antigen and CRP levels as prognostic biomarkers in recurrent oral cavity squamous cell carcinoma.The effect of resistance exercise on all-cause mortality in cancer survivors.The modified glasgow prognostic score is an independent prognostic factor in patients with inoperable thoracic esophageal squamous cell carcinoma undergoing chemoradiotherapyEffect of RAAS inhibition on the incidence of cancer and cancer mortality in patients with glomerulonephritis.The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma.Pre-treatment levels of C-reactive protein and squamous cell carcinoma antigen for predicting the aggressiveness of pharyngolaryngeal carcinoma.Role of traditional and new biomarkers in breast carcinogenesis.A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell CarcinomaModified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapyThe relationship between tumour necrosis, tumour proliferation, local and systemic inflammation, microvessel density and survival in patients undergoing potentially curative resection of oesophageal adenocarcinomaPrognostic Significance of Serum Inflammatory Response Markers in Newly Diagnosed Non-Small Cell Lung Cancer before ChemoirradiationSerum markers of CYFRA 21-1 and C-reactive proteins in oral squamous cell carcinoma.High anabolic potential of essential amino acid mixtures in advanced nonsmall cell lung cancer.Wheel Balanced Cancer Therapy for Longer Than 21 Days Can Have a Positive Effect on the Survival of Patients with Stage IV CancerThe pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical NephrectomyPrognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular CarcinomaModified glasgow prognostic score as a prognostic factor in gastriccancer patients: a systematic review and meta-analysisA systematically structured review of biomarkers of dying in cancer patients in the last months of life; An exploration of the biology of dying.Changes of acute-phase protein levels in the serum of lung cancer patients following radiotherapyEvaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer.Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancerThe longitudinal relationship between circulating concentrations of C-reactive protein, interleukin-6 and interleukin-10 in patients undergoing resection for renal cancer.Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer.An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer.The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer.Potential tumor biomarkers identified in ovarian cyst fluid by quantitative proteomic analysis, iTRAQ.The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer.Patterns of care and outcomes of older versus younger patients with metastatic pancreatic cancer: A Fox Chase Cancer Center experience.Neutrophil-lymphocyte and platelet-lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinoma.An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer.A Prognostic Model Using Inflammation- and Nutrition-Based Scores in Patients With Metastatic Gastric Adenocarcinoma Treated With ChemotherapyEffect of exercise on markers of inflammation in breast cancer survivors: the Yale exercise and survivorship study.
P2860
Q25255845-7C18C19C-C404-41C7-8C74-2B280C093072Q26771133-890FB0D4-4251-418A-95E9-BF9245DE2390Q28066268-0EAA8E56-C66D-47F0-A6FD-FB8E9BD82CB2Q28069864-F771D334-8424-4F57-8347-374827638111Q33574461-AB045601-E3C7-4B8B-BF75-537B6B63D799Q33576398-C8B2A2AB-19FE-4136-8E07-50125F793E0DQ33686719-DAB518EE-EE69-4F19-B7F2-02EF1B6C7E4BQ33952265-A7FB2721-0908-4582-8275-7C922317D18FQ34019217-B2C4C96B-57BD-4AD7-B331-D4FBABF7D92BQ34241072-2953FBED-5AA5-45F5-96A0-CB11EECAFD26Q34451915-FB463AA5-A000-4402-B108-F5EF2A70942EQ34572243-FCEC0D11-99A6-4867-8C13-1F716B417F89Q34576411-DD02B8FC-C376-4540-A49A-E1B8C7A7D660Q35572905-8F988D21-D810-4132-A269-96367F174560Q35781911-527755AD-4A3C-44D9-8844-EE0C05287C30Q35851207-AEDF9CFA-B045-4383-88B3-7DCBC56BD1C6Q35879893-4DD177E1-CD97-4BBC-BEAF-7A803F9D673DQ35960578-5EB2C2C4-70A5-4A69-87B6-AE7B17A8115DQ35986621-8FCE2BB2-8752-47D5-8ADA-18B48018C3ECQ36000203-5BE6AFBA-ECB1-4AF2-B203-E1A20B09B6DEQ36070272-AFD2B2D6-0E25-4362-BDD7-2B0BA0013C84Q36124168-B8987544-D59A-46E6-B3CE-60A21AFF51E1Q36148206-0A0BE73D-E716-45A6-9AED-DAA6E2276A18Q36194925-5CE13595-5E8B-46C8-B2C8-0B6AEFADCCA4Q36317466-68F2AA10-E8A3-41C6-8D8C-A6112ADB8881Q36338248-064B164C-8AB3-4723-B307-EE95DC8AA87CQ36449810-63A27E5C-2E8B-4FEA-8090-1180F0776F59Q36610116-EEAB4F23-5CAE-4535-A26A-8397440ABB19Q36611485-448A5B29-C7AC-4E7F-BABC-1C96F12C0CD8Q36612383-57E724F1-F456-4008-85A8-3E4D96509C36Q36612480-9F821C1E-C41F-44B9-A96D-67A0215BDF8BQ36614306-7B064C7D-8FEE-4D9B-85C5-DC528341EC6CQ36623998-3E46407C-61F9-44B6-A9C5-996BA759A3C9Q36797835-62AAED64-E3C5-4297-AA4F-D1FE3F9C92C2Q36935954-814F279D-456B-49C5-A44F-3CCF1BBAFF12Q37038460-D35ED19F-3DB7-4F7C-B605-36BB2D64AE49Q37129614-EFC95F76-2A5A-4AC8-9970-CAA2F4EB4FFFQ37152934-3BDEA12E-A9B9-4918-A46F-8FCD1729D86EQ37206464-C4940D44-21CD-41D9-A629-A5AD780862AAQ37339174-3BE7D034-829F-436C-9286-3841678C1759
P2860
Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Measurement of the systemic in ...... vival in patients with cancer.
@en
Measurement of the systemic in ...... vival in patients with cancer.
@nl
type
label
Measurement of the systemic in ...... vival in patients with cancer.
@en
Measurement of the systemic in ...... vival in patients with cancer.
@nl
prefLabel
Measurement of the systemic in ...... vival in patients with cancer.
@en
Measurement of the systemic in ...... vival in patients with cancer.
@nl
P2093
P1433
P1476
Measurement of the systemic in ...... vival in patients with cancer.
@en
P2093
Angerson WJ
Johnstone J
McArdle CS
McMillan DC
P356
10.1207/S15327914NC41-1&2_8
P577
2001-01-01T00:00:00Z